Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys

Brain Research

Volumn 738, Issue 1, 1996, Pages 53-59

  Di Monte, Donato A ^a   DeLanney, Louis E ^a   Irwin, Ian ^a   Royland, Joyce E ^a   Chan, Piu ^a   Jakowec, Michael W ^a   Langston, J William ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

deprenyl; dopamine; L DOPA; monkey; monoamine oxidase; parkinsonism; striatum; substantia nigra

Indexed keywords

CLORGYLINE; DIHYDROXYPHENYLACETIC ACID; HOMOVANILLIC ACID; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; SELEGILINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0030605146     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00761-5     Document Type: Article

References (27)

1. Azzaro A.J., King J., Kotzuk J., Schoepp D.D., Frost J., Schochet S. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization and affinity for substrate in synaptic dopamine metabolism. J. Neurochem. 45:1985;949-956.
2. Birkmayer W., Knoll J., Riederer P., Youdim M.B. (-)-Deprenyl leads to prolongation of L-DOPA efficacy in Parkinson's disease. Mod. Probl. Pharmacopsych. 19:1983;170-176.
3. Butcher S.P., Fairbrother I.S., Kelly J.S., Arbuthnott G.W. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum. J. Neurochem. 55:1990;981-988.
4. Buu N.T., Angers M. Effects of different monoamine oxidase inhibitors on the metabolism of L-DOPA in the rat brain. Biochem. Pharmacol. 36:1987;1731-1735.
5. DeBoer, P., Wachtel, S.R. and Abercrombie, E.D., Biochemistry and pharmacology of L-DOPA in relation to basal ganglia circuitry. In G. Percheron, J.S. McKenzie and J. Feger (Eds.), The Basal Ganglia IV, Plenum Press, New York, 1994, pp. 395-401.
6. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32:1992;804-812.
7. Fowler C.J., Wiberg A., Oreland L., Marcusson J., Winblad B. The effect of age on the activity and molecular properties of human brain monoamine oxidase. J. Neural Trans. 49:1980;1-20.
8. Garrett M.C., Soares-da-Silva P. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissue from the brain of the rat. Neuropharmacology. 29:1990;875-879.
9. Glover V., Sandler M., Owen F., Riley G.J. Dopamine is a monoamine oxidase B substrate in man. Nature. 265:1977;80-81.
10. Irwin I., DeLanney L.E., Forno L.S., Finnegan K.T., Di Monte D.A., Langston J.W. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Brain Res. 531:1990;242-252.
11. Irwin I., DeLanney L.E., McNeill T., Chan P., Forno L.S., Murphy G.R., Di Monte D.A., Sandy M.S., Langston J.W. Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration. 3:1994;251-265.
12. Kato T., Dong B., Ishii K., Kinemuchi H. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats. J. Neurochem. 46:1986;1277-1282.
13. Kilpatrick I., Jones M., Phillipson O. A semiautomated analysis method for catecholamines, indoleamines and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation. J. Neurochem. 46:1986;1865-1876.
14. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N. Engl. J. Med. 318:1988;876-880.
15. Levitt P., Pintar J.E., Breakefieid X.O. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc. Natl. Acad. Sci. USA. 79:1982;6385-6389.
16. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Moratalla R., Quinn B., DeLanney L.E., Irwin I., Langston J.W., Graybiel A.M. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 89:1992;3859-3863.
18. Paterson I.A., Juorio A.V., Berry M.D., Zhu M.Y. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. J. Pharmacol. Exp. Ther. 258:1991;1019-1026.
19. Riachi N.J., Harik S.I. Monoamine oxidases of the brains and livers of macaque and cercopithecus monkeys. Exp. Neurol. 115:1992;212-217.
20. Semenoff D., Kimelberg H.K. Autoradiography of high affinity uptake of catecholamine by primary astrocyte cultures. Brain Res. 348:1985;125-136.
21. Spina M.B., Cohen G. Exposure of striatal synaptosomes to L-DOPA increases levels of oxidized glutathione. J. Pharmacol. Exp. Ther. 247:1988;502-507.
22. Tetrud J.W., Langston J.W. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science. 245:1989;519-522.
23. The Parkinson Study Group Effect of deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 321:1989;1364-1371.
24. Wachtel S.R., Abercrombie E.D. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors. J. Neurochem. 63:1994;108-117.
25. Westlund K.N., Denney R.M., Kochersperger L.M., Rose R.M., Abell C.W. Distinct monoamine oxidase A and B populations in primate brain. Science. 230:1985;181-183.
26. Willoughby J., Glover V., Sandler M., Albanese A., Jenner P., Marsden C.D. Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity. Neurosci. Lett. 90:1988;100-106.
27. Yu P.H., Hertz L. Differential expression of type A and type B monoamine oxidase of mouse astrocytes in primary cultures. J. Neurochem. 39:1982;1492-1495.